Restricted accessResearch articleFirst published online 2018-8
Effect of Open- vs Closed-Cell Stent Design on Periprocedural Outcomes and Restenosis After Carotid Artery Stenting: A Systematic Review and Comprehensive Meta-analysis
Purpose:To compare periprocedural complications and in-stent restenosis rates associated with open- vs closed-cell stent designs used in carotid artery stenting (CAS). Methods: A systematic search was conducted to identify all randomized and observational studies published in English up to October 31, 2017, that compared open- vs closed-cell stent designs in CAS. Identified studies were included if they reported the following outcomes: stroke, transient ischemic attack (TIA), myocardial infarction (MI), hemodynamic depression, new ischemic lesions detected on imaging, and death within 30 days, as well as the incidence of in-stent restenosis. A random-effects model meta-analysis was employed. Model results are reported as the odds ratio (OR) and 95% confidence interval (CI). The I2 statistic was used to assess heterogeneity. Results: Thirty-three studies (2 randomized trials) comprising 20, 291 patients (mean age 71.3±3.0 years; 74.6% men) were included. Patients in the open-cell stent group had a statistically significant lower risk of restenosis ⩾40% (OR 0.42, 95% CI 0.19 to 0.92; I2=0%) and ⩾70% (OR 0.23, 95% CI 0.10 to 0.52; I2=0%) at a mean follow-up of 24 months. No statistically significant differences were identified for periprocedural stroke, TIA, new ischemic lesions, MI, hemodynamic depression, or death within 30 days after CAS. Sensitivity analysis of the 2 randomized controlled trials only did not point to any significant differences either. Conclusion: Use of open-cell stent design in CAS is associated with a decreased risk for restenosis when compared to the closed-cell stent, without significant differences in periprocedural outcomes.
BrottTGHobsonRW2ndHowardGet al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23.
2.
YadavJSWholeyMHKuntzREet al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501.
3.
SardarPChatterjeeSAronowHDet al. Carotid artery stenting versus endarterectomy for stroke prevention a meta-analysis of clinical trials. J Am Coll Cardiol. 2017;69:2266–2275.
4.
EconomopoulosKPSergentanisTNTsivgoulisGet al. Carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes. Stroke. 2011;42:687–692.
5.
TadrosROMalikRKVouyoukaAGet al. A systematic review of carotid stent design and selection : strategies to optimize procedural outcomes. Interv Cardiol. 2013;5:203–211.
BosiersMDelooseKVerbistJet al. The impact of embolic protection device and stent design on the outcome of CAS. Perspect Vasc Surg Endovasc Ther. 2008;20:272–279.
8.
TadrosROSpyrisCTVouyoukaAGet al. Comparing the embolic potential of open and closed cell stents during carotid angioplasty and stenting. J Vasc Surg. 2012;56:89–95.
9.
MorrSLinNSiddiquiAH.Carotid artery stenting: current and emerging options. Med Devices (Auckl). 2014;7:343–355.
10.
ShamseerLMoherDClarkeMet al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
11.
SterneJAHernanMAReevesBCet al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
12.
HigginsJPTAltmanDGGøtzschePCet al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
13.
HigginsJPTThompsonSGDeeksJJet al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
14.
BosiersMde DonatoGDelooseKet al. Does free cell area influence the outcome in carotid artery stenting ?Eur J Vasc Endovasc Surg. 2007;141:135–141.
15.
SchillingerMGschwendtnerMReimersBet al. Does carotid stent cell design matter ?Stroke. 2008;39:905–910.
16.
JimJRubinBGLandisGSet al. Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomes. J Vasc Surg. 2009;54:71–79.
17.
GrunwaldIQReithWKarpKet al. Comparison of stent free cell area and cerebral lesions after unprotected carotid artery stent placement. Eur J Vasc Endovasc Surg. 2012;43:10–14.
18.
MammoDFChengCRaginaNPet al. Factors affecting cardiovascular and cerebrovascular complications of carotid artery stenting in Northern Michigan: a retrospective study. Cardiovasc Revasc Med. 2017;18(5S1):S18–S21.
19.
StabileEGiuglianoGCremonesiAet al. Impact on outcome of different types of carotid stent : results from the European Registry of Carotid Artery Stenting. EuroIntervention. 2016;12:e265–e270.
20.
DoigDTurnerELDobsonJet al. Predictors of stroke, myocardial infarction or death within 30 days of carotid artery stenting: results from the International Carotid Stenting Study. Eur J Vasc Endovasc Surg. 2016;51:327–334.
21.
AlparslanBFatihOUlkuNet al. The effect of stent cell geometry on carotid stenting outcomes. Cardiovasc Intervent Radiol. 2016;39:507–513.
22.
KonoKShintaniATeradaT.Non-enhanced magnetic resonance angiography can evaluate restenosis after carotid artery stenting with the Carotid Wallstent. Acta Neurochir (Wien). 2014;156:1713–1719.
23.
GiriJKennedyKFWeinbergIet al. Comparative effectiveness of commonly used devices for carotid artery stenting: an NCDR analysis (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2014;7:171–177.
24.
de DonatoGSetacciFSirignanoPet al. Optical coherence tomography after carotid stenting: rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg. 2013;45:579–587.
25.
PierceDSRoseroEBModrallJGet al. Open-cell versus closed-cell stent design differences in blood flow velocities after carotid stenting. J Vasc Surg. 2009;49:602–606.
26.
BlaselSHattingenEBerkefeldJet al. Evaluation of angiographic and technical aspects of carotid stenting with diffusion-weighted magnetic resonance imaging. Cardiovasc Intervent Radiol. 2009;32:666–671.
27.
HartJPPeetersPVerbistJet al. Do device characteristics impact outcome in carotid artery stenting ?J Vasc Surg. 2006;44:725–730.
28.
HussainHGAparajitaRKhanSZet al. Closed-cell stents present with higher velocities on duplex ultrasound compared with open-cell stents after carotid intervention: short- and mid-term results. Ann Vasc Surg. 2011;25:55–63.
29.
KesslerIGoryBMacianFet al. Carotid artery stenting in patients with symptomatic carotid stenosis: a single-center series. J Neuroradiol. 2013;40:38–44.
30.
LealIOrgazAFloresAet al. A diffusion-weighted magnetic resonance imaging–based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. J Vasc Surg. 2012;56:1585–1590.
YounisGAGuptaKMortazaviAet al. Original studies predictors of carotid stent restenosis. Catheter Cardiovasc Interv. 2007;682:673–682.
33.
WholeyMHWholeyMHTanWAet al. A comparison of balloon-mounted and self-expanding stents in the carotid arteries: immediate and long-term results of more than 500 patients. J Endovasc Ther. 2003;10:171–181.
34.
SonSChoiDSKimS-Ket al. Carotid artery stenting in patients with near occlusion: a single-center experience and comparison with recent studies. Clin Neurol Neurosurg. 2013;115:1976–1981.
35.
SakamotoSKiuraYKajiharaY.Carotid artery stenting using the proximal or dual protection method for near occlusion of the cervical internal carotid artery. Neurosurg Rev. 2013;36:551–557.
36.
MurakamiMHatanoTMiyakoshiAet al. Follow-up after undersized dilatation of targeted lesions in carotid artery stenting. Br J Neurosurg. 2015;29:661–667.
37.
OhkiTVeithFJGrenellSet al. Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg. 2002;36:1175–1185.
38.
NantoMGotoYYamamotoHet al. Vasopressor after carotid artery stenting. Neurol Med Chir (Tokyo). 2017;57:115–121.
39.
CirbianJEchanizGGeneAet al. Incidence and timing of hypotension after transcervical carotid artery stenting: correlation with postoperative complications. Catheter Cardiovasc Interv. 2014;1018:1013–1018.
40.
NiiKTsutsumiMAikawaHet al. Incidence of hemodynamic depression after carotid artery stenting using different self-expandable stent types. Neurol Med Chir (Tokyo). 2011;51:556–560.
41.
SahinMAcarGOzkanBet al. Comparison of short-term outcomes after carotid artery stenting according to different stent designs. Postepy Kardiol Interwencyjnej. 2013;9:121–125
42.
MaleuxGMarrannesJHeyeSet al. Outcome of carotid artery stenting at 2 years follow-up: comparison of nitinol open cell versus stainless steel closed cell stent design. J Cardiovasc Surg (Torino). 2009;50:669–675.
43.
DiehmNKatzenBTDickFet al. Influence of stent type on hemodynamic depression after carotid artery stent placement. J Vasc Interv Radiol. 2007;19:23–30.
44.
TimaranCHRoseroEBHigueraAet al. Randomized clinical trial of open-cell vs closed-cell stents for carotid stenting and effects of stent design on cerebral embolization. J Vasc Surg. 2011;54:1310–1316.e1.
45.
ParkKYKimDIKimBMet al. Incidence of embolism associated with carotid artery stenting: open-cell versus closed-cell stents. J Neurosurg. 2013;119:642–647.
46.
KouvelosGNPatelisNAntoniouGAet al. Meta-analysis of the effect of stent design on 30-day outcome after carotid artery stenting. J Endovasc Ther. 2015;22:789–797.
47.
CasseseSNdrepepaGKingLAet al. Proximal occlusion versus distal filter for cerebral protection during carotid stenting: updated meta-analysis of randomised and observational MRI studies. EuroIntervention. 2015;11:238–246.
48.
GuptaRAbou-CheblABajzerCTet al. Rate, predictors, and consequences of hemodynamic depression after carotid artery stenting. J Am Coll Cardiol. 2006;47:1538–1543.
49.
MlekuschWSchillingerMSabetiSet al. Hypotension and bradycardia after elective carotid stenting: frequency and risk factors. J Endovasc Ther. 2003;10:557–565.
KhanMALiuMWChioFLet al. Predictors of restenosis after successful carotid artery stenting. Am J Cardiol. 2003;92:895–897.
52.
HunterGC.EdgarJ.Poth Memorial/W.L. Gore and Associates, Inc. Lectureship. The clinical and pathological spectrum of recurrent carotid stenosis. Am J Surg. 1997;174:583–588.
53.
AbuRahmaAFAbu-HalimahSHassSMet al. Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis. J Vasc Surg. 2010;52:1180–1187.
54.
GoelSAGuoL-WLiuBet al. Mechanisms of post-intervention arterial remodelling. Cardiovasc Res. 2012;96:363–371.
55.
Willfort-EhringerAAhmadiRGschwandtnerMEet al. Healing of carotid stents: a prospective duplex ultrasound study. J Endovasc Ther. 2003;10:636–642.
56.
FarbAWeberDKKolodgieFDet al. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105:2974–2980.
57.
TrisalVPaulsonTHansSSet al. Carotid artery restenosis: an ongoing disease process. Am Surg. 2002;68:275–280.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
